GlassScriptPhysician profile
Karen Bohaty
NPI 1811998792
$4,976.60
in general payments reported to CMS, 2019-2025
22 companies · $1,222 in 2025
The $1,222 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $535 · 2022: $800 · 2023: $966 · 2024: $1,453 · 2025: $1,222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,641.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,641.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,285.53 | 2021-2025 | |
| Janssen Biotech, INC. | $685.03 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| E.R. Squibb & Sons, L.L.C. | $655.73 | 2022-2025 | Sotyktu |
| Amgen INC. | $358.47 | 2022-2025 | Otezla, Otezla |
| Genzyme Corporation | $325.67 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $307.56 | 2021-2025 | Blu-U |
| Pfizer INC. | $278.77 | 2021-2025 | |
| Lilly USA, LLC | $235.17 | 2022-2025 | Taltz, Olumiant, Ebglyss |
| Novartis Pharmaceuticals Corporation | $218.62 | 2021-2025 | |
| Dermavant Sciences, INC. | $130.55 | 2022-2024 | Vtama |
| Ucb, INC. | $117.65 | 2021-2025 | Bimzelx |
| Leo Pharma INC. | $87.72 | 2022-2025 | Anzupgo, Adbry |
| Almirall LLC | $48.20 | 2021-2022 | |
| Galderma Laboratories, L.P. | $45.47 | 2025 | Nemluvio |
| Incyte Corporation | $41.44 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $38.39 | 2024 | |
| Organon LLC | $26.35 | 2024-2025 | Vtama |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.82 | 2024 | Spevigo |
| Regeneron Healthcare Solutions, INC. | $22.43 | 2022 | |
| Botanix Sb INC | $17.55 | 2025 | Sofdra |
| Genentech USA, INC. | $14.13 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.35 | 2024 | Arazlo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Bohaty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.